Beacon Therapeutics
Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.
About Beacon Therapeutics
Beacon Therapeutics is a biotechnology firm in the clinical stage focused on preserving and enhancing vision for individuals affected by both uncommon and widespread eye disorders. The organization is leveraging the revolutionary potential of gene therapy to achieve significant results for serious eye conditions. Currently, Beacon's pipeline is aimed at severe retinal diseases that cause blindness, including X-linked retinitis pigmentosa (XLRP) and geographic atrophy.
Company Facts
- Headquarters
- Alachua
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00101_00250
- Funding Stage
- late_stage_venture
- Total Funding
- $365,139,662
- Last Funding Type
- series_c
- Last Funding Date
- 2026-01-08
- Website
- beacontx.com
Industries & Categories
Biotechnology, Health Care, Life Science, Therapeutics
Social Links
Canonical: https://fsome.com/organization/beacon-therapeutics-3560 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.